Form 8-K - Current report:
SEC Accession No. 0000950170-24-130432
Filing Date
2024-11-25
Accepted
2024-11-25 08:46:08
Documents
13
Period of Report
2024-11-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kant-20241125.htm   iXBRL 8-K 70763
2 EX-99.1 kant-ex99_1.htm EX-99.1 65187
3 GRAPHIC img118959689_0.jpg GRAPHIC 123916
  Complete submission text file 0000950170-24-130432.txt   431001

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kant-20241125.xsd EX-101.SCH 30886
16 EXTRACTED XBRL INSTANCE DOCUMENT kant-20241125_htm.xml XML 4534
Mailing Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040
Business Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 241492124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)